CLC Number:
| [1] Ryu JH, Sekiguchi H, Yi ES. Pulmonary manifestations of immunoglobulin G4-related sclerosing disease [J]. Eur Respir J, 2012, 39(1): 180-186. [2] Muller R, Habert P, Ebbo M, et al. Thoracic involvement and imaging patterns in IgG4-related disease [J]. Eur Respir Rev, 2021, 30(162): 210078. doi:10.1183/16000617.0078-2021. [3] Matsui S, Yamamoto H, Minamoto S, et al. Proposed diagnostic criteria for IgG4-related respiratory disease [J]. Respir Investig, 2016, 54(2): 130-132. [4] Wand O, Fox BD, Shtraichman O, et al. Non-tuberculous, adenosine deaminase-positive lymphocytic pleural effusion: consider immunoglobulin G4-related disease [J]. Sarcoidosis Vasc Diffuse Lung Dis, 2020, 37(2): 225-230. [5] Saito Z, Yoshida M, Kojima A, et al. Characteristics of pleural effusion in IgG4-related pleuritis [J]. Respir Med Case Rep, 2020, 29: 101019. doi:10.1016/j.rmcr.2020.101019. [6] Fei Y, Shi J, Lin W, et al. Intrathoracic involvements of immunoglobulin G4-related sclerosing disease [J]. Medicine(Baltimore), 2015, 94(50): e2150. doi:10.1097/MD.0000000000002150. [7] Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases[J]. Am J Surg Pathol, 2010, 34(12): 1812-1819. [8] 王静, 刘粉, 曾荣, 等. 以胸膜病变为特征的IgG4相关性肺疾病1例[J]. 山东大学学报(医学版), 2022, 60(3): 114-116. [9] Shimoda M, Tanaka Y, Morimoto K, et al. IgG4-related pleural effusion with high adenosine deaminase levels: a case report and literature review [J]. Medicine(Baltimore), 2021, 100(11): e25162. doi:10.1097/MD.0000000000025162. [10] Mizushina Y, Shiihara J, Nomura M, et al. Immunoglobulin G4-related pleuritis complicated with minimal change disease [J]. Intern Med, 2022, 61(5): 723-728. [11] Zhou J, Peng Y, Peng L, et al. Serum IgE in the clinical features and disease outcomes of IgG4-related disease: a large retrospective cohort study [J]. Arthritis Res Ther, 2020, 22(1): 255. doi: 10.1186/s13075-020-02338-1. [12] Tanabe T, Tsushima K, Yasuo M, et al. IgG4-associated multifocal systemic fibrosis complicating sclerosing sialadenitis, hypophysitis, and retroperitoneal fibrosis, but lacking pancreatic involvement [J]. Intern Med, 2006, 45(21): 1243-1247. [13] Yamamoto H, Suzuki T, Yasuo M, et al. IgG4-related pleural disease diagnosed by a re-evaluation of chronic bilateral pleuritis in a patient who experienced occasional acute left bacterial pleuritis [J]. Intern Med, 2011, 50(8): 893-897. [14] Goag EK, Park JE, Lee EH, et al. A case of extensive IgG4-related disease presenting as massive pleural effusion, mediastinal mass, and mesenteric lymphadenopathy in a 16-year-old male [J]. Tuberc Respir Dis(Seoul), 2015, 78(4): 396-400. [15] Tong X, Bai M, Wang W, et al. IgG4-related disease involving polyserous effusions with elevated serum interleukin-6 levels: a case report and literature review [J]. Immunol Res, 2017, 65(4): 944-950. [16] Yu T, Wu Y, Liu J, et al. The risk of malignancy in patients with IgG4-related disease: a systematic review and meta-analysis [J]. Arthritis Res Ther, 2022, 24(1): 14. doi:10.1186/s13075-021-02652-2. [17] Liang QL, Shi HZ, Wang K, et al. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis [J]. Respir Med, 2008, 102(5): 744-754. [18] Mei F, Mancini M, Maurizi G, et al. Pleural involvement in IgG4-related disease: case report and review of the literature [J]. Diagnostics(Basel), 2021, 11(12): 2177. doi:10.3390/diagnostics11122177. [19] Doita S, Tamura T, Baba T, et al. A case of immunoglobulin G4-related disease with pleural effusion, requiring exclusion of tuberculous pleurisy [J]. Respir Med Case Rep, 2022, 37: 101654. doi:10.1016/j.rmcr.2022.101654. [20] Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use [J]. Rheum Dis Clin North Am, 2016, 42(1): 157-176. [21] Murata Y, Aoe K, Mimura-Kimura Y, et al. Association of immunoglobulin G4 and free light chain with idiopathic pleural effusion [J]. Clin Exp Immunol, 2017, 190(1): 133-142. [22] Shimada H, Kato Y, Okuda M, et al. Pleuritis associated with immunoglobulin G4-related disease under normal thoracoscopic findings: a case report [J]. J Med Case Rep, 2021, 15(1): 241. doi:10.1186/s13256-021-02718-4. [23] Liu Y, Yang F, Chi X, et al. Needle biopsy compared with surgical biopsy: pitfalls of small biopsy in histologial diagnosis of IgG4-related disease [J]. Arthritis Res Ther, 2021, 23(1): 54. doi:10.1186/s13075-021-02432-y. [24] Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases [J]. Am J Surg Pathol, 2009, 33(12): 1886-1893. [25] Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease [J]. Arthritis Rheumatol, 2020, 72(1): 7-19. [26] Murata Y, Aoe K, Mimura Y. Pleural effusion related to IgG4 [J]. Curr Opin Pulm Med, 2019, 25(4): 384-390. [27] Sakata K, Kikuchi J, Emoto K, et al. Refractory IgG4-related pleural disease with chylothorax: a case report and literature review [J]. Intern Med, 2021, 60(13): 2135-2143. [28] Karim AF, Verdijk RM, Guenoun J, et al. An inflammatory condition with different faces: immunoglobulin G4-related disease [J]. The Netherlands journal of medicine, 2016, 74(3): 110-115. [29] Kasashima S, Kawashima A, Ozaki S, et al. Clinicopathological features of immunoglobulin G4-related pleural lesions and diagnostic utility of pleural effusion cytology [J]. Cytopathology, 2019, 30(3): 285-294. [30] Campochiaro C, Della-Torre E, Lanzillotta M, et al. Long-term efficacy of maintenance therapy with Rituximab for IgG4-related disease [J]. Eur J Intern Med, 2020, 74: 92-98. doi:10.1016/j.ejim.2019.12.029. [31] Makimoto G, Ohashi K, Taniguchi K, et al. Long-term spontaneous remission with active surveillance in IgG4-related pleuritis: a case report and literature review [J]. Respir Med Case Rep, 2019, 28: 100938. doi:10.1016/j.rmcr.2019.100938. [32] 刘俊秀, 王佳鑫, 于墨池, 等. 表现为胸腔积液的IgG4相关性疾病一例 [J]. 中华医学杂志, 2021, 101(1): 71-72. |
| [1] | LI Xiang, ZHANG Yi, WANG Xuechun, XU Mengchao, WANG Yuelan. Research progress on oxidative stress in acute lung injury induced by traumatic brain injury [J]. Journal of Shandong University (Health Sciences), 2025, 63(2): 118-124. |
| [2] | Xiao LI,Zhiyuan SUN,Longjiang ZHANG. Research advances of artificial intelligence-based medical imaging in the screening, diagnosis and prediction of pneumonia [J]. Journal of Shandong University (Health Sciences), 2023, 61(12): 13-20. |
| [3] | . [J]. Journal of Shandong University (Health Sciences), 2022, 60(11): 124-126. |
| [4] | YANG Xuan, LI Yanzhi, MA Wei, JIA Chongqi. Causal influence of lung function on risk of fatality of COVID-19: a two-sample Mendelian randomization study [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 104-111. |
| [5] | Consensus Group of Diagnosis and Treatment for Coronavirus Disease 2019, Qilu Hospital of Shandong University. Diagnosis, management, prevention and control for suspected cases of coronavirus disease 2019, Qilu Hospital criteria [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 1-7. |
| [6] | LI Shixue, SHAN Ying. Latest research advances on novel coronavirus pneumonia [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 19-25. |
| [7] | HU Zhao, WANG Qiang. Coronavirus disease 2019 infection associated kidney injury [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 26-31. |
| [8] | JU Xiuli. Potential mechanism and research progress of mesenchymal stem cells in the treatment of 2019 novel coronavirus pneumonia [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 32-37. |
| [9] | ZHOU Shengyu, WANG Chunting, ZHANG Wei, WANG Ximing, DONG Liang. Clinical characteristics and treatment effect of 537 cases of novel coronavirus pneumonia in Shandong Province [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 44-51. |
| [10] | WEN Peng, DONG Liang, WANG Xin, WEI Min, LIU Yan, XU Yurong, SUN Wenqing, ZHOU Mingxiang. Severe novel coronavirus pneumonia: a case report and literature review [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 58-61. |
| [11] | ZHANG Xiaoguo, MA Yan, XIAO Jiaan, ZHANG Zhongfa. Clinical characteristics of novel coronavirus pneumonia in children in Jinan [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 62-64. |
| [12] | GU Jianhua, MA Xiaotian, LI Jiqing, XUE Fuzhong, WANG Jialin. Risk prediction model of chronic obstructive pulmonary disease in health management cohort [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 62-65. |
| [13] | LAI Guoxiang, WANG Qing. Clinical application of bronchoscopy in the airway management of patients undergoing mechanical ventilation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 14-18. |
| [14] | MENG Wei, WU Dawei, SHAN Tichao, ZHANG Fan, GUO Haipeng, LIU Yu, DING Shifang, ZHAI Qian. Tigecycline in treating ventilator-associated pneumonia in critically ill patients [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(4): 71-75. |
| [15] | PAN Qing, LÜ Zhifang. Clinical application value of the new guide for patients with chronic obstructive pulmonary disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 63-67. |
|
||
